Literature DB >> 1387413

Inhibition of lecithin:cholesterol acyltransferase activity by synthetic phosphatidylcholine species containing eicosapentaenoic acid or docosahexaenoic acid in the sn-2 position.

J S Parks1, T Y Thuren, J D Schmitt.   

Abstract

Phospholipids isolated from the plasma of monkeys fed a diet enriched in fish oil were poor substrates for cholesteryl ester (CE) synthesis by the lecithin:cholesterol acyltransferase (LCAT) reaction relative to those from animals fed a lard containing diet when the phospholipids were used for the preparation of recombinant particles by cholate dialysis (Parks, J. S., B. C. Bullock, and L. L. Rudel. 1989. J. Biol. Chem. 264: 2545-2551). The purpose of the present study was to directly test the influence of eicosapentaenoic acid (20:5 n-3) and docosahexaenoic acid (22:6 n-3) in the sn-2 position of phosphatidylcholine (PC) on the activity of LCAT. PC species containing 1-palmitoyl-2-oleoyl PC (POPC), 1-palmitoyl-2-linoleoyl PC (PLPC), 1-palmitoyl-2-arachidonoyl PC (PAPC), 1-palmitoyl-2-eicosapentaenoyl PC (PEPC), or 1-palmitoyl-2-docosahexaenoyl PC (PDPC) were purchased or synthesized and made into recombinant particles of uniform size and composition with [14C]cholesterol and apoA-I using the cholate dialysis procedure. The recombinant particles (PC:cholesterol:apoA-I molar ratio = 42:1.9:1) exhibited the following order of reactivity towards purified human LCAT in vitro: POPC greater than PLPC greater than PEPC = PAPC greater than PDPC. The apparent Vmax/Km for recombinant particles containing PEPC and PDPC was 17% and 7% that of particles containing POPC, respectively. There was a linear decrease in CE formation when the percentage of PEPC or PDPC was increased from 0 to 100% relative to POPC in recombinant particles with a constant PC:cholesterol:apoA-I molar ratio, suggesting that the PEPC and PDPC were competitive inhibitors of the LCAT reaction.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1387413

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  6 in total

1.  Surface properties of native human plasma lipoproteins and lipoprotein models.

Authors:  J B Massey; H J Pownall
Journal:  Biophys J       Date:  1998-02       Impact factor: 4.033

2.  The acute effects of a single very high dose of n-3 fatty acids on plasma lipids and lipoproteins in healthy subjects.

Authors:  N Svaneborg; J M Møller; E B Schmidt; K Varming; H H Lervang; J Dyerberg
Journal:  Lipids       Date:  1994-02       Impact factor: 1.880

3.  Dietary polyunsaturated fat decreases interaction between low density lipoproteins and arterial proteoglycans.

Authors:  J M Manning; A K Gebre; I J Edwards; W D Wagner; L L Rudel; J S Parks
Journal:  Lipids       Date:  1994-09       Impact factor: 1.880

4.  Lecithin:cholesterol acyltransferase: role of N-linked glycosylation in enzyme function.

Authors:  K O; J S Hill; X Wang; R McLeod; P H Pritchard
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

5.  A protective lipidomic biosignature associated with a balanced omega-6/omega-3 ratio in fat-1 transgenic mice.

Authors:  Giuseppe Astarita; Jennifer H McKenzie; Bin Wang; Katrin Strassburg; Angela Doneanu; Jay Johnson; Andrew Baker; Thomas Hankemeier; James Murphy; Rob J Vreeken; James Langridge; Jing X Kang
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

Review 6.  Distinguishing health benefits of eicosapentaenoic and docosahexaenoic acids.

Authors:  Fraser D Russell; Corinna S Bürgin-Maunder
Journal:  Mar Drugs       Date:  2012-11-13       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.